BNP Paribas Asset Management Holding S.A. - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP Paribas Asset Management Holding S.A. ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2024$990
-71.1%
1,000,000
-71.4%
0.00%
-66.7%
Q1 2024$3,431
-0.3%
3,500,0000.0%0.01%
-10.0%
Q4 2023$3,441
+0.6%
3,500,0000.0%0.01%0.0%
Q3 2023$3,420
-0.5%
3,500,0000.0%0.01%
-9.1%
Q2 2023$3,438
-2.9%
3,500,0000.0%0.01%
-8.3%
Q1 2023$3,541
-5.7%
3,500,0000.0%0.01%
-7.7%
Q4 2022$3,755
-99.9%
3,500,0000.0%0.01%
-7.1%
Q3 2022$3,532,000
-95.0%
3,500,000
-16.2%
0.01%
-94.8%
Q2 2022$70,578,000
+1924.6%
4,175,000
+19.3%
0.27%
+2141.7%
Q1 2022$3,486,000
-95.3%
3,500,000
-16.2%
0.01%
-95.2%
Q4 2021$74,141,000
+1.6%
4,175,0000.0%0.25%
-8.5%
Q3 2021$72,948,000
-0.9%
4,175,0000.0%0.27%
+3.4%
Q2 2021$73,603,000
+1949.7%
4,175,000
+19.3%
0.26%
+1646.7%
Q1 2021$3,591,000
-4.0%
3,500,0000.0%0.02%
-11.8%
Q4 2020$3,740,000
+2.0%
3,500,0000.0%0.02%
-19.0%
Q3 2020$3,668,000
-14.4%
3,500,0000.0%0.02%
-27.6%
Q2 2020$4,285,000
+18.1%
3,500,0000.0%0.03%
-6.5%
Q1 2020$3,628,000
-1.7%
3,500,0000.0%0.03%
+24.0%
Q4 2019$3,690,000
+6.4%
3,500,0000.0%0.02%
-7.4%
Q3 2019$3,467,000
-4.3%
3,500,0000.0%0.03%
-10.0%
Q2 2019$3,624,000
+1.3%
3,500,0000.0%0.03%0.0%
Q1 2019$3,576,0003,500,0000.03%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2021
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 25,130,000$26,845,0003.25%
ZAZOVE ASSOCIATES LLC 33,935,000$35,929,0003.11%
Cheyne Capital Management (UK) LLP 3,000,000$3,179,0001.89%
ADVENT CAPITAL MANAGEMENT /DE/ 73,250,000$77,604,0001.60%
Sonora Investment Management, LLC 7,390,000$7,792,0001.08%
Lombard Odier Asset Management (Europe) Ltd 11,613,000$12,391,0000.86%
SSI INVESTMENT MANAGEMENT LLC 6,083,000$6,421,0000.50%
MACKAY SHIELDS LLC 53,388,000$57,017,0000.44%
OAKTREE CAPITAL MANAGEMENT LP 18,865,000$20,150,0000.27%
LOOMIS SAYLES & CO L P 907,254$120,544,0000.24%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders